Physiological and pathophysiological role of magnesium in the cardiovascular system: Implications in hypertension

Journal of Hypertension

Volumn 18, Issue 9, 2000, Pages 1177-1191

  Laurant, Pascal ^a   Touyz, Rhian M ^b  

^a UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^b CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

Blood pressure; Calcium; Cations; Magnesium deficiency; Pre eclampsia; Vascular smooth muscle cells

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; CALCIUM ION; CARBACHOL; CYCLIC AMP; ENDOTHELIN 1; GLUTATHIONE PEROXIDASE; INSULIN; ISOPRENALINE; MAGNESIUM ION; MAGNESIUM SULFATE; NORADRENALIN; POTASSIUM ION; SODIUM ION; SOMATOMEDIN; VASOPRESSIN;

BLOOD PRESSURE REGULATION; BLOOD VESSEL FUNCTION; CARDIOVASCULAR SYSTEM; CELL LEVEL; DISEASE COURSE; HEMODYNAMICS; HUMAN; HYPERTENSION; MAGNESIUM DEFICIENCY; MAGNESIUM METABOLISM; PATHOGENESIS; PATHOPHYSIOLOGY; PREECLAMPSIA; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

EID: 0033821519     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200018090-00003     Document Type: Review

References (210)

1. Magnesium and cell cycle control: An update
2. Magnesium as a regulatory cation: Criteria and evaluation
3. Magnesium in cardiovascular biology
4. 2+ and vascular contractility
5. Magnesium, calcium, sodium and potassium status in normotensive and hypertensive Johannesburg residents
6. Serum ionized magnesium: Relation to blood pressure and racial factors
7. Relationship of dietary sodium, potassium, calcium, and magnesium with blood pressure. Belgian Interuniversity Research on Nutrition and Health
8. 2+ concentrations in a subgroup of hypertensives. Membrane model for the pathogenesis of primary hypertension
9. Effects of magnesium supplementation in hypertensive patients. Assessment by office, home, and ambulatory blood pressures
10. + in platelets and erythrocytes of essential hypertensive patients: Relation to blood pressure
11. Intestinal absorption of magnesium from food supplements
12. Cellular magnesium transport in the vertebrate intestine
13. Magnesium absorption: Mechanics and the influence of vitamin D, calcium and phosphate
14. Parathyroid hormone increases bone formation and improves mineral balance in vitamin D-deficient female rats
15. 2+ from heart and liver mitochondria following the interaction of thyroid hormone with the adenine nucleotide translocase
16. Hypomagnesemia: Renal magnesium handling
17. Renal magnesium handling: New insights in understanding old problems
18. Control of magnesium transport in the thick ascending limb
19. Laboratory evaluation of magnesium status. Renal function and free intracellular magnesium concentration
20. Genetic disorders of renal electrolyte transport
21. Atomic absorption spectrometry of magnesium
22. Methods for the estimation of serum magnesium in clinical laboratories
23. Assessment of magnesium status
24. Laboratory tests for the assessment of magnesium status in humans
25. Determination of serum magnesium concentration by clinical laboratories
26. Methods for measurement of intracellular magnesium: NMR and fluorescence
27. NMR measurement of cytosoilc free calcium, free magnesium, and intracellular sodium in the aorta of the normal and spontaneously hypertensive rat
28. 2+ indicators with greatly improved fluorescence properties
29. 2+ and other metals
30. A fluorescent indicator for measuring cytosolic free magnesium
31. Measurement of intracellular magnesium in a vascular smooth muscle cell line using a fluorescent probe
32. 2+ influx pathway
33. Role of magnesium on calcium responses to vasopressin in vascular smooth muscle of spontaneously hypertensive rats
34. 2+ changes in a vascular smooth muscle cell line
35. Mysteries of magnesium homeostasis
36. Mechanisms of magnesium transport
37. 2+ exchange in heart cells
38. 2+ transport locus of Salmonella typhimurium encodes a P-type ATPase
39. +-dependent protein kinase C-pathways
40. 2+ from an intracellular pool in rat sublingual mucous acini
41. Changes in magnesium content and subcellular distribution during retinoic acid-induced differentiation of HL60 cells
42. Cell magnesium transport and homeostasis: Role of intracellular compartments
43. Effects of glutathione on red blood cell intracellular magnesium. Relation to glucose metabolism
44. 2+ uptake in liver
45. 2+]; in vascular smooth muscle cells
46. Regulation of magnesium uptake and release in the heart and in isolated ventricular myocytes
47. Magnesium responsiveness to insulin and insulin-like growth factor 1 in erythrocytes from normotensive and hypertensive subjects
48. 2+ accumulation by insulin in rat hearts and cardiac ventricular myocytes
49. 2+ efflux from liver cells
50. Subcellular calcium and magnesium mobilization in rat liver stimulated in vivo with vasopressin and glucagon
51. Intralymphocyte free magnesium in patients with primary aldosteronism
52. 2+) - ATPase of sarcoplasmic reticulum
53. Intracellular magnesium blocks sodium outward currents in a voltage- and dose-dependent manner
54. Magnesium, the mimic/antagonist of calcium
55. 2+ ions and GTP in frog ventricular myocytes
56. The role of magnesium in nucleic acid and protein metabolism
57. Regulation of phosphoinositide phospholipases by hormones, neurotransmitters and other agonists linked to G proteins
58. Sustained diacylglycerol formation from inositol phospholipids in Ang II-stimulated vascular smooth muscle cells
59. Divalent cation regulation of phosphoinositide metabolism
60. Translocation of phospholipase C-gamma 2 induced by in vitro activation of protein tyrosine kinase activity in mast cell lysates
61. Modulation of the affinity of the vasopressin receptor by magnesium ions
62. 2+
63. Electron probe microanalysis of calcium release and magnesium uptake by endoplasmic reticulum in bee photoreceptors
64. Extracellular calcium-sensing receptor; implications for calcium and magnesium handling in the kidney
65. 2+
66. A comparative study of the activation of protein kinase C alpha by different diacylglycerol isomers
67. 2+ uptake in mouse distal convoluted tubule cells
68. 2+ influx in prawn oocytes
69. Altered effects of insulin in hypertension: Role of basal ion levels in determining cellular responsiveness
70. Effect of magnesium on vascular tone and reactivity, in pressurized mesenteric arteries from SHR
71. Effects of magnesium on human umbilical arteries: Role of intracellular calcium stores
72. 2- permeable non-selective cation currents in aortic smooth muscle cells
73. 2+ entry in vascular smooth muscle cells
74. 2+
75. Magnesium regulates intracellular free ionized calcium concentration and cell geometry in VSMC
76. 2+-permeable non-selective cation currents in aortic smooth muscle cells
77. 2+ in guinea-pig basilar artery smooth muscle cells
78. Altered cations and muscle membrane ATPase activity in SHR with benign and malignant hypertension
79. Intracellular free magnesium levels in vascular smooth and striated muscle cells of SHR
80. Cellular calcium and magnesium metabolism in the pathophysiology and treatment of hypertension and related metabolic disorders
81. + exchanger in red blood cells from essential hypertensive patients
82. 2+ transport in vascular smooth muscle cells from spontaneously hypertensive rats
83. Uremia in acute glomerular nephritis: The cause and treatment in children
84. Myocardial contractility and performance capacity after magnesium infusions in young healthy persons: A double-blind, placebo-controlled, cross-over study
85. Hemodynamic effects of magnesium sulfate on the normal heart
86. Intracellular ionic consequences of dietary salt loading in essential hypertension. Relation to blood pressure and effects of calcium channel blockade
87. Magnesium-induced vasodilation is comparable to that induced by calcium channel blockade
88. 2+ and vascular contractility. Miner
89. Comparative effects of magnesium salts on reactivity of arterioles and venules to constrictors agents: An in situ study on microcirculation
90. 2+ in young patients with borderline hypertension
91. In vivo and in vitro effects of magnesium sulphate in the cerebrovascular bed of the goat
92. Effect of magnesium sulphate on the noradrenaline-induced cerebral vasoconstrictor and pressor responses in the goat
93. 2+ versus organic calcium channel blockers on myogenic tone and agonist-induced responsiveness of blood vessels
94. Effect of magnesium on the tone of isolated human coronary arteries. Comparison with diltiazem and nitroglycerin
95. Magnesium sulphate reverses the carotid vasoconstriction caused by endothelin-1, angiotensin II and neuropeptide-Y, but not that caused by N(G)-nitro-L-arginine methyl ester, in conscious rats
96. Magnesium is essential in mechanisms of pulmonary vasomotor control
97. Signal transduction and regulation in smooth muscle
98. 2+ entry into vascular smooth muscle cells
99. 2+ release in human vascular endothelial cells
100. +
101. A novel potent vasoconstrictor peptide produced by vascular endothelial cells
102. The role of prostacyclin in vascular tissue
103. Magnesium-deficiency elevates circulating levels of inflammatory cytokines and endothelin
104. Endothelin-1-induced contraction in isolated aortae from normotensive and DOCA-salt hypertensive rats: Effect of magnesium
105. Action of magnesium sulfate on platelet interaction and prostacyclin of blood vessels
106. Effect of magnesium sulfate infusion upon plasma prostaglandins in preeclampsia and preterm labor
107. Magnesium sulfate: Rationale for its use in preeclampsia
108. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia
109. Role of free radicals and substance P in magnesium deficiency
110. Ang II-stimulated generation of reactive oxygen species in human vascular smooth muscle cells is mediated via PLD-dependent pathways
111. NADPH oxidase. Role in cardiovascular biology and disease
112. Oxidative stress in vascular damage in hypertension
113. Endothelium-dependent relaxation in canine coronary arteries requires magnesium ions
114. Magnesium inhibits basal release of endothelium-derived relaxing factor in canine coronary arteries
115. Differential effect of magnesium on basal and agonist-induced EDRF relaxation in canine coronary arteries
116. Antagonistic modulatory roles of magnesium and calcium on release of endothelium-derived relaxing factor and smooth muscle tone
117. Role of endothelium in the response of human intracranial arteries to a slight reduction of extracellular magnesium
118. Influence of extracellular magnesium on the contractile and endothelium-dependent dilatory responses of feline mesenteric arteries
119. Hypomagnesemia inhibits nitric oxide release from coronary endothelium: Protective role of magnesium infusion after cardiac operations
120. Hypertension and magnesium in rats: Relationship to microcirculation and calcium
121. Influence of endothelium in the in vitro vasorelaxant effect of magnesium on aortic basal tension in DOCA-salt hypertensive rat
122. 2+-induced relaxation in noradrenaline-contracted aorta from DOCA-salt hypertensive rat
123. Electrolyte content of serum, erythrocyte, kidney and heart tissue in salt induced hypertensive rats
124. Disturbances of magnesium metabolism in the spontaneously hypertensive rats
125. Dietary magnesium supplementation modifies blood pressure and cardiovascular function in mineralocorticoid-salt hypertensive rats but not in normotensive rats
126. Mineral balance and blood pressure in the young spontaneously hypertensive rat
127. Abnormal magnesium metabolism in two rat models of genetic hypertension
128. 31P NMR study
129. Intralymphocytic free calcium and magnesium in stroke-prone spontaneously hypertensive rats and effects of blood pressure and various antihypertensive agents
130. Magnesium, calcium and trace elements in spontaneously hypertensive rats
131. A comparison of free intracellular calcium and magnesium levels in the vascular smooth muscle and striated muscle cells of the spontaneously hypertensive and Wistar Kyoto normotensive rat
132. 2+ uptake by intestinal brush-border membrane of spontaneously hypertensive rats
133. Time-course change of the blood pressure level in magnesium-deficient rats
134. Effect of magnesium deficiency on blood pressure and mechanical properties of rat carotid artery
135. Effect of moderate magnesium deficiency on serum lipids, blood pressure and cardiovascular reactivity in normotensive rats
136. Magnesium and blood pressure. I. Animal studies
137. Relation of magnesium intake and other dietary factors to blood pressure the Honolulu Heart Study
138. Magnesium and blood pressure: Review of the epidemiologic and clinical trial experience
139. Dietary calcium, potassium, magnesium and blood pressure in the Netherlands
140. Nutrient intake and blood pressure in the Dietary Intervention Study in children
141. A prospective study of nutritional factors and hypertension among US men
142. Dietary magnesium intake and blood pressure: A qualitative overview of the observational studies
143. The effects of potassium, magnesium, calcium and fiber on risk of stroke
144. Dietary approaches to stop hypertension: A summary of study results. DASH Collaborative Group
145. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group
146. Prospective study of nutritional factors, blood pressure and hypertension among US women
147. Dietary electrolyte intake and blood pressure in older subjects: The Rotterdam Study
148. Calcium and magnesium in drinking water and the risk of death from hypertension
149. Lack of blood pressure effect with calcium and magnesium supplementation in adults with high-normal blood pressure. Results from phase 1 of the Trials of Hypertension Prevention (TOHP)
150. Intralymphocyte free magnesium and calcium and insulin tolerance test in a group of essential hypertensive patients
151. 2+ concentration in a subgroup of hypertensive s-cell models for the pathogenesis of primary hypertension
152. 2+ in essential hypertension
153. The effect of angiotensin II on platelet intracellular free magnesium and calcium ionic concentrations in essential hypertension
154. Intracellular free magnesium in erythrocytes of essential hypertension
155. Increased erythrocyte magnesium in never treated essential hypertension
156. Abnormal magnesium status in patients with cardiovascular diseases
157. Ionic disturbances of calcium and magnesium metabolism in essential hypertension
158. Direct magnetic resonance determination of aortic distensibility in essential hypertension. Relation to age, abdominal visceral fat, and in situ intracellular free magnesium
159. Alterations in intracellular cations and cell membrane ATPase activity in patients with malignant hypertension
160. Skeletal muscle magnesium and potassium by gender and hypertensive status
161. Ionic basis of hypertension, insulin resistance, vascular disease and related disorders: Mechanisms of Syndrome X
162. Hypomagnesemia and diabetes mellitus
163. Magnesium in disease: A review with special emphasis on the serum ionized magnesium
164. Magnesium. An update on physiological, clinical and analytical aspects
165. Lack of effect of oral magnesium on high blood pressure: A double blind study
166. Long-term magnesium supplementation in essential hypertension
167. Effect of magnesium on blood pressure and intracellular ion levels of Brazilian hypertensive patients
168. Extracellular and intracellular magnesium depletion in preganancy and gestational diabetes
169. Relations between magnesium, calcium and plasma renin activity in black and white hypertensive patients
170. Platelet magnesium depletion in normotensive and hypertensive obese subjects: The role of salt-regulating hormones and catecholamines
171. Hypertension development in Dahl S and R rats on high salt-low potassium diet: Calcium, magnesium and sympathetic nervous system
172. Dietary calcium and magnesium supplements in spontaneously hypertensive rats and isolated arterial reactivity
173. Blood pressure and plasma renin activity after magnesium supplementation in the spontaneously hypertensive rat: A study during developing and established hypertension
174. Effects of dietary sodium and magnesium on cyclosporin A-induced hypertension and nephrotoxicity in spontaneously hypertensive rats
175. Dietary magnesium does not affect blood pressure in spontaneously hypertensive rats
176. Lack of magnesium supplementation effects on blood pressure and vascular responsiveness in aged spontaneously hypertensive rats
177. Effects of dietary magnesium supplementation on the development of hypertension in spontaneously hypertensive rat
178. Magnesium supplementation attenuates, but does not prevent, the development of hypertension in spontaneously hypertensive rats
179. Effect of age on in vitro magnesium modulation of vascular reactivity in the rat aorta
180. The dose-dependent reduction in blood pressure through administration of magnesium. A double blind placebo controlled cross-over study
181. The effects of high oral magnesium supplementation on blood pressure, serum lipids and realted variables in apparently healthy Japanese subjects
182. Oral magnesium supplementation in patients with essential hypertension
183. Reduction in blood pressure with a sodium-reduced potassium-and magnesium-enriched salt in subjects with mild essential hypertension
184. Effect of magnesium on blood pressure
185. Effect of a mineral salt diet on 24 h blood pressure monitoring in elderly hypertensive patients
186. Preliminary communication on intralymphocyte ionized magnesium in hypertensive patients under treatment with beta-blockers
187. Race, education and dietary cations: Findings from the third national health and nutrition examination survey
188. Blood pressure response during long-term treatment with magnesium is dependent on magnesium status. A double-blind, placebo-controlled study in essential hypertension and in subjects with high-normal blood pressure
189. Expression of platelet-derived growth factor-A mRNA in human placenta: Effect of magnesium infusion in pre-eclampsia
190. Fetal ionized magnesium levels parallel maternal levels during magnesium sulfate therapy for preeclampsia
191. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure
192. Hypertension in pregnancy. New recommendations for management
193. Pre-eclampsia: More than pregnancy-induced hypertension
194. Preeclampsia: An endothelial cell disorder
195. Magnesium sulfate: Rationale for its use in preeclampsia
196. Effect of magnesium sulfate on maternal brain blood flow in preeclampsia: A randomized, placebo-controlled study
197. Cardiovascular alterations in severe pregnancy-induced hypertension: Acute effects of intravenous magnesium sulfate
198. Favorable hemodynamic effects of magnesium sulfate in preeclampsia
199. Evidence that prostacyclin mediates the vascular action of magnesium in humans
200. Effect of magnesium sulfate infusion upon plasma prostaglandins in preeclampsia and preterm labor. Hypertens
201. Ionized serum magnesium and potassium levels in pregnant women with preeclampsia and eclampsia
202. Serum ionized levels in normal and preeclamptic gestation
203. Intracellular and extracellular ionized and total magnesium in pre-ecalmpsia and uncomplicated pregnancy
204. Mononuclear cell magnesium content remains unchanged in various cell hypertensive disorders of pregnancy
205. Serum and intracellular magnesium during normal pregnancy and in patients with preeclampsia
206. 2+ concentrations in preeclamspis
207. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia
208. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Trial
209. A randomised controlled trial of intravenous magnesium sulfate vs. placebo in the management of women with preeclampsia
210. Anticonvulsants for preecalmpsia